I too have had discussions with Vertex, and I've made representations to you about a particular constituent of mine, who I know is very concerned that her daughter, who's only about seven years old, can have access to this drug. But, in my discussions with Vertex, I've been, like you, hugely frustrated—they seem to understand what the process is, but, for whatever reason, are not engaging in the way that they know that they have to. But my question to you is: if those proper processes were followed by Vertex, and Orkambi was to meet all the tests of both NICE and the All Wales Medicines Strategy Group, would it then be eligible under the new treatment fund?